|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berretta R, Merisio C, Melpignano M, Rolla
M, Ceccaroni M, De Ioris A, Patrelli TS and Nardelli GB: Vaginal
versus abdominal hysterectomy in endometrial cancer: A
retrospective study in a selective population. Int J Gynecol
Cancer. 18:797–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
International Agency for Research on
Cancer (IARC). World Cancer Report. 2014, Steward BW and Wild CP:
IARC; Lyon: pp. 465–481. 2014
|
|
5
|
Lortet-Tieulent J, Ferlay J, Bray F and
Jemal A: International patterns and trends in endometrial cancer
incidence, 1978-2013. J Natl Cancer Inst. 110:354–361. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matthews J and Gustafsson JA: Estrogen
signaling: A subtle balance between ER alpha and ER beta. Mol
Interv. 3:281–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumura S, Ohta T, Yamanouchi K, Liu Z,
Sudo T, Kojimahara T, Seino M, Narumi M, Tsutsumi S, Takahashi T,
et al: Activation of estrogen receptor α by estradiol and cisplatin
induces platinum-resistance in ovarian cancer cells. Cancer Biol
Ther. 18:730–739. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Habata S, Iwasaki M, Sugio A, Suzuki M,
Tamate M, Satohisa S, Tanaka R and Saito T: BAG3 increases the
invasiveness of uterine corpus carcinoma cells by suppressing
miR-29b and enhancing MMP2 expression. Oncol Rep. 33:2613–2621.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Felzen V, Hiebel C, Koziollek-Drechsler I,
Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C and Morawe T:
Estrogen receptor α regulates non-canonical autophagy that provides
stress resistance to neuroblastoma and breast cancer cells and
involves BAG3 function. Cell Death Dis. 6:e18122015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brendel A, Felzen V, Morawe T, Manthey D
and Behl C: Differential regulation of apoptosis-associated genes
by estrogen receptor alpha in human neuroblastoma cells. Restor
Neurol Neurosci. 31:199–211. 2013.PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugio A, Iwasaki M, Habata S, Mariya T,
Suzuki M, Osogami H, Tamate M, Tanaka R and Saito T: BAG3
upregulates Mcl-1 through downregulation of miR-29b to induce
anticancer drug resistance in ovarian cancer. Gynecol Oncol.
134:615–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gorai I, Doi C and Minaguchi H:
Establishment and characterization of carcinosarcoma cell line of
the human uterus. Cancer. 71:775–786. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsumoto M, Yamaguchi Y, Seino Y,
Hatakeyama A, Takei H, Niikura H, Ito K, Suzuki T, Sasano H,
Yaegashi N and Hayashi SI: Estrogen signaling ability in human
endometrial cancer through the cancer-stromal interaction. Endocr
Relat Cancer. 15:451–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jing X, Peng J, Dou Y, Sun J, Ma C, Wang
Q, Zhang L, Luo X, Kong B, Zhang Y, et al: Macrophage ERα promoted
invasion of endometrial cancer cell by mTOR/KIF5B-mediated
epithelial to mesenchymal transition. Immunol Cell Biol.
97:563–576. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heldring N, Pike A, Andersson S, Matthews
J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M and
Gustafsson JA: Estrogen receptors: How do they signal and what are
their targets. Physiol Rev. 87:905–931. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dahlman-Wright K, Cavailles V, Fuqua SA,
Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M,
Parker MG and Gustafsson JA: International union of pharmacology.
LXIV. Estrogen receptors. Pharmacol Rev. 58:773–781. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li SF, Shiozawa T, Nakayama K, Nikaido T
and Fujii S: Stepwise abnormality of sex steroid hormone receptors,
tumor suppressor gene products (p53 and Rb), and cyclin E in
uterine endometrioid carcinoma. Cancer. 77:321–329. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shih HC, Shiozawa T, Kato K, Imai T,
Miyamoto T, Uchikawa J, Nikaido T and Konishi I:
Immunohistochemical expression of cyclins, cyclin-dependent
kinases, tumor-suppressor gene products, Ki-67, and sex steroid
receptors in endometrial carcinoma: Positive staining for cyclin A
as a poor prognostic indicator. Hum Pathol. 34:471–478. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steele R, Mott JL and Ray RB: MBP-1
upregulates miR-29b that represses Mcl-1, collagens, and
matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer.
1:381–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garzon R, Heaphy CE, Havelange V, Fabbri
M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA,
et al: MicroRNA 29b functions in acute myeloid leukemia. Blood.
114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Wang H, Tao K, Xiao Q, Huang Z,
Zhong L, Cao W, Wen J and Feng W: miR-29b suppresses CML cell
proliferation and induces apoptosis via regulation of BCR/ABL1
protein. Exp Cell Res. 319:1094–1101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao JJ, Lin J, Lwin T, Yang H, Guo J,
Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, et al:
microRNA expression profile and identification of miR-29 as a
prognostic marker and pathogenetic factor by targeting CDK6 in
mantle cell lymphoma. Blood. 115:2630–2639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Y, Crawford M, Mao Y, Lee RJ, Davis IC,
Elton TS, Lee LJ and Nana-Sinkam SP: Therapeutic delivery of
MicroRNA-29b by cationic lipoplexes for lung cancer. Mol Ther
Nucleic Acids. 2:e842013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang X, Schwind S, Yu B, Santhanam R,
Wang H, Hoellerbauer P, Mims A, Klisovic R, Walker AR, Chan KK, et
al: Targeted delivery of microRNA-29b by transferrin-conjugated
anionic lipopolyplex nanoparticles: A novel therapeutic strategy in
acute myeloid leukemia. Clin Cancer Res. 19:2355–2367.
2013.PubMed/NCBI
|
|
29
|
Sieghart W, Losert D, Strommer S, Cejka D,
Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia
BP, Peck-Radosavljevic M and Wacheck V: Mcl-1 overexpression in
hepatocellular carcinoma: A potential target for antisense therapy.
J Hepatol. 44:151–157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akgul C: Mcl-1 is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aichberger KJ, Mayerhofer M, Krauth MT,
Skvara H, Florian S, Sonneck K, Akgul C, Derdak S, Pickl WF,
Wacheck V, et al: Identification of mcl-1 as a BCR/ABL-dependent
target in chronic myeloid leukemia (CML): Evidence for cooperative
antileukemic effects of imatinib and mcl-1 antisense
oligonucleotides. Blood. 105:3303–3311. 2005. View Article : Google Scholar : PubMed/NCBI
|
